# Implantation and Injectable Dosage Form New Animal Drugs; Imidocarb Dipropionate
> **Food and Drug Administration** · Final rule. · Published 1997-12-23 · Effective 1997-12-23 · 62 FR 66983
## Document
- **Document number:** 97-33486
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 62 FR 66983
- **CFR reference:** 21 CFR 522
- **Publication date:** 1997-12-23
- **Effective date:** 1997-12-23
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Schering-Plough Animal Health Corp. The NADA provides for subcutaneous or intramuscular use of imidocarb dipropionate solution for dogs for treatment of babesiosis.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1997/12/23/97-33486/implantation-and-injectable-dosage-form-new-animal-drugs-imidocarb-dipropionate)
---
*AI Analytics · CC0 1.0*